Arrowhead Pharmaceuticals Stock Price - ARWR

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 47.90 ▲ 0.46 (0.97%)
Company Name Stock Ticker Symbol Market Type
Arrowhead Pharmaceuticals Inc ARWR NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -1.06 -2.19% 47.44 47.84 45.22 47.00 48.50 23:59:45
Bid Price Ask Price Spread Spread % News
47.45 47.90 0.45 0.94% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
16,579 2,376,157 $ 46.96 $ 111,586,276 1,468,994 10.41 - 49.78
Last Trade Time Type Quantity Stock Price Currency
19:45:08 formt 170 $ 47.90 USD

Arrowhead Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 4.52B 95.30M $ -54.45M -0.66 93.30 90.52M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Arrowhead Pharmaceuticals News

Loading Messages....

Latest ARWR Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ARWR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week40.0049.7839.3246.321,742,6507.4418.6%
1 Month36.8949.7835.0340.751,545,30310.5528.6%
3 Months32.0349.7825.9734.611,405,94315.4148.11%
6 Months18.3849.7817.8929.141,673,85029.06158.11%
1 Year11.8949.7810.4123.061,609,41235.55298.99%
3 Years4.4449.781.2013.101,559,24643.00968.47%
5 Years6.0249.781.2010.771,427,36241.42688.04%

Arrowhead Pharmaceuticals Description

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Your Recent History
Arrowhead ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.